Description

Semax is a modified fragment of adrenocorticotropic hormone (ACTH) and is researched for its influence on brain-derived neurotrophic factor (BDNF) signaling and synaptic plasticity.

Laboratory research commonly examines Semax’s effects on memory processing, learning pathways, and resistance to neurological stressors. Its non-hormonal structure makes it suitable for focused neurocognitive studies.

OxygenLab’s Semax is manufactured with precision to ensure stable peptide activity across neurological research applications.

Produced in the United States, this peptide meets high purity standards for advanced cognitive research.